These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Functional characterization of the rat mdr1b encoded P-glycoprotein: not all inducing agents are substrates. Santoni-Rugiu E; Silverman JA Carcinogenesis; 1997 Nov; 18(11):2255-63. PubMed ID: 9395229 [TBL] [Abstract][Full Text] [Related]
3. Characterization of two pituitary GH3 cell sublines partially resistant to apoptosis induction by okadaic acid. Ritz V; Marwitz J; Richter E; Ziemann C; Quentin I; Steinfelder HJ Biochem Pharmacol; 1997 Nov; 54(9):967-71. PubMed ID: 9374416 [TBL] [Abstract][Full Text] [Related]
4. Doxorubicin-resistant LoVo adenocarcinoma cells display resistance to apoptosis induction by some but not all inhibitors of ser/thr phosphatases 1 and 2A. Sieder S; Richter E; Becker K; Heins R; Steinfelder HJ Toxicology; 1999 Jun; 134(2-3):109-15. PubMed ID: 10403630 [TBL] [Abstract][Full Text] [Related]
5. Human leukemia K562 cell mutant (K562/OA200) selected for resistance to okadaic acid (protein phosphatase inhibitor) lacks protein kinase C-epsilon, exhibits multidrug resistance phenotype, and expresses drug pump P-glycoprotein. Zheng B; Chambers TC; Raynor RL; Markham PN; Gebel HM; Vogler WR; Kuo JF J Biol Chem; 1994 Apr; 269(16):12332-8. PubMed ID: 7512966 [TBL] [Abstract][Full Text] [Related]
6. Multidrug-resistant human KB carcinoma cells are highly resistant to the protein phosphatase inhibitors okadaic acid and calyculin A. Analysis of potential mechanisms involved in toxin resistance. Chambers TC; Raynor RL; Kuo JF Int J Cancer; 1993 Jan; 53(2):323-7. PubMed ID: 8093882 [TBL] [Abstract][Full Text] [Related]
7. Multidrug resistance in androgen-independent growing rat prostate carcinoma cells is mediated by P-glycoprotein. Siegsmund MJ; Kreukler C; Steidler A; Nebe T; Köhrmann KU; Alken P Urol Res; 1997; 25(1):35-41. PubMed ID: 9079744 [TBL] [Abstract][Full Text] [Related]
8. Up-regulation of P-glycoprotein expression in rat liver cells by acute doxorubicin treatment. Fardel O; Lecureur V; Daval S; Corlu A; Guillouzo A Eur J Biochem; 1997 May; 246(1):186-92. PubMed ID: 9210482 [TBL] [Abstract][Full Text] [Related]
9. Mussel blood cells, resistant to the cytotoxic effects of okadaic acid, do not express cell membrane p-glycoprotein activity (multixenobiotic resistance). Svensson S; Särngren A; Förlin L Aquat Toxicol; 2003 Oct; 65(1):27-37. PubMed ID: 12932699 [TBL] [Abstract][Full Text] [Related]
10. Inhibitors of mdr1-dependent transport activity delay accumulation of the mdr1 substrate rhodamine 123 in primary rat hepatocyte cultures. Hirsch-Ernst KI; Ziemann C; Rustenbeck I; Kahl GF Toxicology; 2001 Oct; 167(1):47-57. PubMed ID: 11557129 [TBL] [Abstract][Full Text] [Related]
11. P-glycoprotein (ABCB1) but not multidrug resistance-associated protein 1 (ABCC1) is induced by doxorubicin in primary cultures of rat astrocytes. Mercier C; Declèves X; Masseguin C; Fragner P; Tardy M; Roux F; Gabrion J; Scherrmann JM J Neurochem; 2003 Nov; 87(4):820-30. PubMed ID: 14622113 [TBL] [Abstract][Full Text] [Related]
13. Human (MDR1) and mouse (mdr1, mdr3) P-glycoproteins can be distinguished by their respective drug resistance profiles and sensitivity to modulators. Tang-Wai DF; Kajiji S; DiCapua F; de Graaf D; Roninson IB; Gros P Biochemistry; 1995 Jan; 34(1):32-9. PubMed ID: 7819214 [TBL] [Abstract][Full Text] [Related]
14. Hamster pancreatic beta cell lines with altered sensitivity towards apoptotic signalling by phosphatase inhibitors. Krautheim A; Brechlin P; Becker K; Winkler M; Steinfelder HJ Br J Pharmacol; 2000 Feb; 129(4):687-94. PubMed ID: 10683193 [TBL] [Abstract][Full Text] [Related]
15. Characterization of multidrug resistance P-glycoprotein transport function with an organotechnetium cation. Piwnica-Worms D; Rao VV; Kronauge JF; Croop JM Biochemistry; 1995 Sep; 34(38):12210-20. PubMed ID: 7547962 [TBL] [Abstract][Full Text] [Related]
16. Overexpression of the multidrug resistance genes mdr1, mdr3, and mrp in L1210 leukemia cells resistant to inhibitors of ribonucleotide reductase. Rappa G; Lorico A; Liu MC; Kruh GD; Cory AH; Cory JG; Sartorelli AC Biochem Pharmacol; 1997 Sep; 54(6):649-55. PubMed ID: 9310341 [TBL] [Abstract][Full Text] [Related]
17. Reactive oxygen species participate in mdr1b mRNA and P-glycoprotein overexpression in primary rat hepatocyte cultures. Ziemann C; Bürkle A; Kahl GF; Hirsch-Ernst KI Carcinogenesis; 1999 Mar; 20(3):407-14. PubMed ID: 10190554 [TBL] [Abstract][Full Text] [Related]
18. Altered MRP is associated with multidrug resistance and reduced drug accumulation in human SW-1573 cells. Eijdems EW; Zaman GJ; de Haas M; Versantvoort CH; Flens MJ; Scheper RJ; Kamst E; Borst P; Baas F Br J Cancer; 1995 Aug; 72(2):298-306. PubMed ID: 7640209 [TBL] [Abstract][Full Text] [Related]
19. Impact of BCRP/MXR, MRP1 and MDR1/P-Glycoprotein on thermoresistant variants of atypical and classical multidrug resistant cancer cells. Stein U; Lage H; Jordan A; Walther W; Bates SE; Litman T; Hohenberger P; Dietel M Int J Cancer; 2002 Feb; 97(6):751-60. PubMed ID: 11857350 [TBL] [Abstract][Full Text] [Related]
20. Effects of the selective bisindolylmaleimide protein kinase C inhibitor GF 109203X on P-glycoprotein-mediated multidrug resistance. Gekeler V; Boer R; Uberall F; Ise W; Schubert C; Utz I; Hofmann J; Sanders KH; Schächtele C; Klemm K; Grunicke H Br J Cancer; 1996 Sep; 74(6):897-905. PubMed ID: 8826855 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]